期刊文献+

肝移植术后稳定期4种抗排斥方案对血糖的影响 被引量:1

The effect of 4 anti-rejection programs on blood glucose in stable period after liver transplantation
下载PDF
导出
摘要 目的回顾性研究分析肝移植术后稳定期4种抗排斥方案应用中出现的血糖异常反应,并对其病因及处理措施进行讨论。方法对肝移植术后稳定期4种抗排斥方案[他克莫司(FK506)联合吗替麦考酚酸酯(MMF)、FK506联合西罗莫司(SRL)、环孢菌素A(CsA)联合MMF、CsA联合SRL]应用中出现的血糖异常反应进行回顾性研究分析,观察空腹血糖受损(im-paired fasting glucose,IFG)、葡萄糖耐量异常(impaired glucose tolerance,IGT)及移植后糖尿病(post transplantation diabetes mellitus,PTDM)的发生率及其对血糖值的影响情况,对其病因及处理措施进行总结和比较。结果 FK506联合MMF组(A组)、FK506联合SRL组(B组)平均血糖水平均高于CsA联合MMF组(C组)和CsA联合SRL(D组),差异均有统计学意义(P<0.01);而A、B组间,C、D组间,平均血糖水平比较差异无统计学意义(P>0.05);IFGI、GT、PTDM发生率在各组间进行两两比较差异均无统计学意义(P>0.05)。结论 FK506相对于CsA对肝移植受者术后的血糖有较大影响,应用以CsA为基础的抗排斥方案,可以降低对患者糖代谢的影响;MMF、SRL对肝移植受者术后的血糖影响相似。 Objective To study and analyze the pathoglycemia responses of 4 anti-rejection programs in stable period after liver transplantation,and to discuss its etiology and treatment.Methods The pathoglycemia responses of 4 anti-rejection programs FK506 unite with MMF,FK506 unite with SRL,CsA unite with MMF,CsA unite with SRL in stable period after liver transplantation were studied and analyzed retrospectively,and the occurrence of impaired fasting glucose(IFG),impaired glucose tolerance(IGT),post transplantation diabetes mellitus(PTDM) and the blood glucose level were observed,and its causes and treatment measures were summarized and compared.Results The levels of group-average blood glucose of FK506 unite with MMF group(A group),FK506 unite with SRL group(B group) were higher than CsA unite with MMF group(C group) and CsA unite with SRL group(D group),and the differences were statistically significant(P0.01).B between A and B group,or C and D group,the differences were no statistically significant(P0.05).Incidence of IFG,IGT and PTDM had no significant difference with multiple comparison in all 4 groups(P0.05).Conclusion FK506 has greater effects compared with CsA on blood glucose of acceptor after liver transplantation,CsA-based anti-rejection programs can reduce the impact to glucose metabolism.MMF and SRL have the similar effects on blood glucose of acceptor after liver transplantation.
作者 肖文波 郑军
出处 《重庆医学》 CAS CSCD 北大核心 2011年第6期540-541,544,共3页 Chongqing medicine
关键词 肝移植 免疫抑制法 高血糖症 liver transplantation immunosuppression hyperglycemia
  • 相关文献

参考文献16

  • 1Montori VM,Basu A,Erwin PJ,et al.Posttransplantation diabetes.A systematic review of the literature[J].Diabetes Care,2002,25:583-592.
  • 2Correia MI,Rego LO,Lima AS.Post-liver transplant obesity and diabetes[J].Curr Opin Clin Nutr Metab Care,2003,6(4):457-460.
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 4European tacrolimus multicenter renal study group.Multicenter randomized trial comparing tacrolimus(FK506)and cyclosporine in the prevention of renal allograft rejection[J].Transplantation,1997,64(6):436.
  • 5Pirsch JD,Miller J,Deierhoi MH,et al.A comparison of tacrolimus(FK506)and cyclosporine for immunosuppression after cadaveric renal transplantation[J].Transplantation,1997,63(7):977.
  • 6刘亚力,王立祥,徐春,朱晓丹.肝移植后糖尿病的病因分析[J].武警医学,2005,16(6):411-413. 被引量:4
  • 7Cpencer CM,Goa KL,Ggillis JC.An update of its pharmacology and clinical efficacy in the management of organ transplantation[J].Drugs,1997,54:925.
  • 8Hahn HJ,Laube F,Lucke S,et al.Toxic effects of cyclosporine on the endocrine pancreas of wistar rats[J].Transplantation,1986,41(8):44-47.
  • 9张启瑜,吴存造,廖毅,虞冠锋,杨亦荣,郑少玲,孙贤斌.不同血药浓度FK506在肝移植术后应用的比较[J].肝胆胰外科杂志,2010,22(2):92-93. 被引量:6
  • 10First MR.Tacrolimus based immunosuppression[J].J Nephrol,2004,17(6):S25-31.

二级参考文献34

  • 1夏伟良,谢海洋,沈岩,吴李鸣,张峰,郑树森.环孢素和他克莫司在体外对乙型肝炎病毒复制影响的对比研究[J].中华医学杂志,2006,86(2):111-115. 被引量:12
  • 2张启瑜,吴存造,虞冠锋,廖毅,杨亦荣,周蒙滔,余正平,郑少玲,孙贤斌,夏鹏,刘勇,蔡勇.三种不同术式原位肝移植的临床研究[J].肝胆胰外科杂志,2006,18(5):271-273. 被引量:6
  • 3卢安卫,郑树森,吴健,梁廷波,王伟林,沈岩,张珉,施邵华,吴应盛.以他克莫司为基础的不同免疫抑制方案在肝移植后应用的比较研究[J].中华医学杂志,2006,86(48):3389-3392. 被引量:7
  • 4Khanna AK.Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus[J].Transplantation,2000,70(4):690-694.
  • 5Jain AB,Kashyap R,Rakela J,et al.Primary adult liver transplantation under tacrolimus:more than 90 months actual follow-up survival and adverse events[J].Liver Transpl Surg,1999,5(2):144-150.
  • 6Panz VR, Bonegio R, Raal FJ et al . Diabetogenic effect of tacrolimus in south African pathients undergoing kidney transplantation . Transplantation,2002,73(4) : 587 - 590.
  • 7Paolillo JA, Boyle GJ, Law YM et al.Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacmlimus- based immunosuppression.Transplantation,2001,71 (2):252.
  • 8Matthews DR , Hosker JP , Rudenski AS et al . Homeostasis model assessment : insulin resistance and β- cell function from fasting plasma glucose and insulin concentration in man.Diabetologia, 1985,28:412.
  • 9Thomas Konrad , Bemd Markus , Carl Allers et al . Impact of cyclosporine and low- dose steroid therapy on insulin sensitivity and bate - cell function in patients with long-termliver grafts . Transplant Int,2001,14:6- 11.
  • 10Cpencer CM , Goa KL , Ggillis JC . An update of its pharmacology and clinical efficacy in the management of organ transplantation . Drugs, 1997,54:925.

共引文献2797

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部